Immucell (ICCC) Receivables - Other (2016 - 2025)
Immucell (ICCC) has disclosed Receivables - Other for 16 consecutive years, with $54341.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Other rose 62.98% year-over-year to $54341.0, compared with a TTM value of $54341.0 through Sep 2025, up 62.98%, and an annual FY2024 reading of $40555.0, up 2.07% over the prior year.
- Receivables - Other was $54341.0 for Q3 2025 at Immucell, up from $44913.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $144916.0 in Q3 2023 and bottomed at $6101.0 in Q2 2023.
- Average Receivables - Other over 5 years is $43367.2, with a median of $40555.0 recorded in 2024.
- The sharpest move saw Receivables - Other plummeted 98.3% in 2021, then skyrocketed 742.57% in 2023.
- Year by year, Receivables - Other stood at $55490.0 in 2021, then decreased by 23.99% to $42178.0 in 2022, then dropped by 5.8% to $39733.0 in 2023, then grew by 2.07% to $40555.0 in 2024, then soared by 33.99% to $54341.0 in 2025.
- Business Quant data shows Receivables - Other for ICCC at $54341.0 in Q3 2025, $44913.0 in Q2 2025, and $56381.0 in Q1 2025.